China Facial Injectable Market Size & Outlook, 2025-2030
Related Markets
China facial injectable market highlights
- The China facial injectable market generated a revenue of USD 1,347.1 million in 2024 and is expected to reach USD 4,162.2 million by 2030.
- The China market is expected to grow at a CAGR of 20.8% from 2025 to 2030.
- In terms of segment, botulinum toxin type a was the largest revenue generating product in 2024.
- HA is the most lucrative product segment registering the fastest growth during the forecast period.
Facial injectable market data book summary
| Market revenue in 2024 | USD 1,347.1 million |
| Market revenue in 2030 | USD 4,162.2 million |
| Growth rate | 20.8% (CAGR from 2025 to 2030) |
| Largest segment | Botulinum toxin type a |
| Fastest growing segment | HA |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Collagen, Botulinum Toxin Type A, HA, CaHA, PLLA |
Other key industry trends
- In terms of revenue, China accounted for 10.7% of the global facial injectable market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China facial injectable market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 4,162.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Facial Injectable Market Scope
Facial Injectable Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Galderma | View profile | 10001+ | Lausanne, Vaud, Switzerland, Europe | http://www.galderma.com |
| Medytox | View profile | 501-1000 | Seoul, Seoul-t'ukpyolsi, South Korea, Asia | http://www.medytox.com/page/company_en?site_id=en |
| Sinclair Pharma plc | View profile | 501-1000 | London, England, United Kingdom, Europe | http://www.sinclairpharma.com/ |
| Merz Pharma | View profile | 5001-10000 | Deutsch, Sachsen, Germany, Europe | http://www.merz.com |
| Revance Therapeutics Inc | View profile | 597 | 1222 Demonbreun Street, Suite 2000, Nashville, TN, United States, 37203 | https://www.revance.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
China facial injectable market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to facial injectable market will help companies and investors design strategic landscapes.
Botulinum toxin type a was the largest segment with a revenue share of 89.66% in 2024. Horizon Databook has segmented the China facial injectable market based on collagen, botulinum toxin type a, ha, caha, plla covering the revenue growth of each sub-segment from 2018 to 2030.
China's Facial Injectable Market is witnessing significant growth, driven by expanding product availability, increasing aesthetic awareness, and growing consumer demand for non-invasive treatments. In May 2024, Galderma launched Restylane VOLYME in China, addressing mid-face aging concerns with its Shape Up Holistic Individualized Treatment (HIT) approach, reflecting a commitment to personalized aesthetic solutions.
Additionally, in September 2024, Allergan Aesthetics introduced BOTOX Cosmetic for the treatment of masseter muscle prominence (MMP), marking it as the first neurotoxin approved in China for this indication. With China’s medical aesthetics market outpacing global growth trends and relatively low market penetration, there remains vast potential for expansion.
As global leaders continue investing in advanced injectables and regulatory approvals increase, China's Facial Injectable Market is set for robust growth, fueled by a rising middle-class population, higher disposable incomes, and a growing emphasis on facial aesthetics.
Reasons to subscribe to China facial injectable market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China facial injectable market databook
-
Our clientele includes a mix of facial injectable market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China facial injectable market , including forecasts for subscribers. This country databook contains high-level insights into China facial injectable market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China Product - Facial Injectable Market size, 2024 - 2030 (US$M)
China Facial Injectable Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
